Folia M, Lombard L, Vergès S, Percodani J, Pessey J J, Serrano E
CHU de Rangueil, Service ORL et Chirurgie Cervico-faciale, 2 avenue Jean Poulhes, F-31403 Toulouse, France.
Rev Laryngol Otol Rhinol (Bord). 2003;124(2):105-10.
Evaluate the long term quality of life in patients after ethmoidectomy associated with intranasal corticotherapy for nasal polyposis on the appreciation of the intensity of nasal symptoms. MATERIAL ET METHOD: The authors report their experience about 203 patients treated by endonasal endoscopic ethmoïdectomy intranasal followed by a long term intransal corticotherapy, with a mean follow up of six years. In this prospective study, each symptom was evaluated using an analogic visual scale and a questionnaire. The evolution of asthma after surgery and the patients global satisfactory rate were noted.
There is a global improvement of the nasal symptoms with a mean postoperative individual scores calculated at 32% for nasal obstruction, at 34% for rhinorrhea and at 51% for anosmia. No impact on asthma or improvement of asthma was encountered in 92% of the patients. The patients global satisfactory rate of this medico-surgical approach of the disease is 93.6%. A positive correlation was found between the severity of the olfactory disorders and the oral corticosteroid therapy.
Endoscopic endonasal ethmoïdectomy followed by intranasal corticotherapy represents a valuable protocol in treating patients with severe nasal polyposis.
通过评估鼻息肉患者鼻窦切除联合鼻内皮质激素治疗后鼻症状的严重程度,来评价其长期生活质量。材料与方法:作者报告了203例接受鼻内镜鼻窦切除术并长期鼻内皮质激素治疗患者的经验,平均随访6年。在这项前瞻性研究中,使用视觉模拟量表和问卷对每种症状进行评估。记录术后哮喘的演变情况以及患者的总体满意率。
鼻症状总体改善,术后平均个体评分显示,鼻塞为32%,流涕为34%,嗅觉减退为51%。92%的患者未出现对哮喘的影响或哮喘改善情况。该疾病的这种药物 - 手术治疗方法的患者总体满意率为93.6%。嗅觉障碍的严重程度与口服皮质激素治疗之间存在正相关。
鼻内镜鼻窦切除术后进行鼻内皮质激素治疗是治疗重度鼻息肉患者的一种有效方案。